Acadia Pharmaceuticals (ACAD) P/E (2010 - 2026)
Acadia Pharmaceuticals (ACAD) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Acadia Pharmaceuticals (ACAD) P/E is 11.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Acadia Pharmaceuticals (ACAD)
| Year | P/E | Change |
|---|---|---|
| 2026 | 11.51 | -0.81% |
| 2025 | 11.60 | -13.97% |
| 2024 | 13.48 | -93.02% |
| 2023 | 193.14 | -793.13% |
| 2022 | -27.86 | -67.68% |
| 2021 | -86.22 | +187.92% |
| 2020 | -29.95 | +11.11% |
| 2019 | -26.95 | +215.63% |
| 2018 | -8.54 | -30.47% |
| 2017 | -12.28 | -10.18% |
| 2016 | -13.67 | -37.51% |
| 2015 | -21.88 | -35.97% |
| 2014 | -34.18 | -39.20% |
| 2013 | -56.21 | +329.16% |
| 2012 | -13.10 | +483.94% |
| 2011 | -2.24 | -57.50% |
| 2010 | -5.28 | N/A |
Comparison Acadia Pharmaceuticals (ACAD) P/E with competitors
Acadia Pharmaceuticals (ACAD) P/E is 11.51.